发表文献

相关文献

Prediction of Local Drug Exposure of Dry Powder Inhaler CXG87 (budesonide/formoterol) Using Physiologically-Based Pharmacokinetic Model
Cao Y, Hu Y, Zhang J, et al.
Prediction of pharmacokinetic / pharmacodynamic properties of aldosterone synthase inhibitors at drug discovery stage using an artificial intelligence-physiologically based pharmacokinetic model.
Zhang M, Wu K, Long S, Jin X, Liu B.
Predicting Drug-Drug Interactions Involving Rifampicin Using a Semi-mechanistic Hepatic Compartmental Model.
Li J, Li X, Wu K, et al.
Predicting pharmacodynamic effects through early drug discovery with artificial intelligence-physiologically based pharmacokinetic (AI-PBPK) modelling.
Wu K, Li X, Zhou Z, et al.
Bioequivalence study of ipratropium bromide inhalation aerosol using PBPK modelling.
Zhang J, Wu K, Liu B, et al.
Predicting the Pharmacokinetics of Orally Administered Drugs across BCS Classes 1-4 by Virtual Bioequivalence Model.
Zhang F, Wu X, Wu K, Yu M, Liu B, Wang H.
In silico prediction of bioequivalence of Isosorbide Mononitrate tablets with different dissolution profiles using PBPK modeling and simulation.
Zhang F, Zhou Y, Wu N, et al.
Accelerating Development of Benziamidazole-Class Proton Pump Inhibitors: A Mechanism-Based PK/PD Model to Optimize Study Design with Ilaprazole as a Case Drug.
Jia R, Zhang F, Wu N, et al.
In Silico Modeling and Simulation to Guide Bioequivalence Testing for Oral Drugs in a Virtual Population.
Zhang F, Jia R, Gao H, Wu X, Liu B, Wang H.
Semi-PBPK Modeling and Simulation to Evaluate the Local and Systemic Pharmacokinetics of OC-01(Varenicline) Nasal Spray.
Wu X, Zhang F, Yu M, et al.
Quantifying Induction/ Inhibition Effects on Fuzuloparib Using a Physiologically Based Pharmaco-Kinetic (PBPK) model.
Li J, Wu K, Li X, Long S, Zhou Z, et al.
Predicting Fluconazole Drug-Drug Interactions Using a Physiologically-based Pharmacokinetic (PBPK) Model.
Li X, Wu K, Zhou Z, Jia R, Zhao Y, et al.